Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-040664

Chief Business Officer sold 75,000 shares at $37.95 ($2,846,310)

  • Chief Business Officer acquired 75,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Parrish Jay Chief Business Officer 2020-07-01 Option exercise +25,925 $1.49 $38,499 248,147 D
Parrish Jay Chief Business Officer 2020-07-01 Option exercise +49,075 $1.58 $77,293 297,222 D
Parrish Jay Chief Business Officer 2020-07-01 Sale −75,000 $37.95 $2,846,310 222,222 D
Derivatives
Parrish Jay Chief Business Officer 2020-07-01 Option exercise · Stock Option (Right to Buy) −25,925 46,296 D
Parrish Jay Chief Business Officer 2020-07-01 Option exercise · Stock Option (Right to Buy) −49,075 62,035 D
Open-market sales · 75,000 sh · avg $37.95 · $2,846,310
Loading xslF345X03/doc4.xml…